Equol inhibits prostate cancer growth through degradation of androgen receptor by S‐phase kinase‐associated protein 2

Chemopreventive and potential therapeutic effects of soy isoflavones have been shown to be effective in numerous preclinical studies as well as clinical studies in prostate cancer. Although the inhibition of androgen receptor signaling has been supposed as one mechanism underlying their effects, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Itsumi, Momoe, Shiota, Masaki, Takeuchi, Ario, Kashiwagi, Eiji, Inokuchi, Junichi, Tatsugami, Katsunori, Kajioka, Shunichi, Uchiumi, Takeshi, Naito, Seiji, Eto, Masatoshi, Yokomizo, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946716/
https://www.ncbi.nlm.nih.gov/pubmed/27088761
http://dx.doi.org/10.1111/cas.12948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946716/
https://www.ncbi.nlm.nih.gov/pubmed/27088761
http://dx.doi.org/10.1111/cas.12948

Ejemplares similares